2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 18, 2023 -- From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published online Dec. 19 in the Annals of Internal Medicine.
Ya-Lin A. Huang, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the number of commercially insured transgender women (TGW) and transgender men (TGM) in the United States and their use of HIV prevention services in a retrospective analysis of secondary data from commercial databases from 2014 to 2021.
The researchers found that from 2014 to 2021, there was an increasing trend in the prevalence of transgender-related diagnosis codes and in the proportion of persons who used gender-affirming hormone therapy (GAHT). Persons aged 18 to 34 years drove the increases. In 2021, 61.1 percent of the 10,613 TGW and 48.3 percent of 4,184 TGM with a test for or a diagnosis of a sexually transmitted infection (STI) in the previous 12 months had an HIV test; of these, 20.2 and 10.2 percent, respectively, were prescribed PrEP. From 2014 to 2021, there was a substantial increase seen in the prevalence of TGW and TGM with a test for or a diagnosis of an STI, who had an HIV test, and who were prescribed PrEP.
"The health and well-being of transgender persons can be increased with holistic service models that include HIV prevention and other prevention services in addition to GAHT," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-19 06:15
Read more
- FDA Approves Xocova (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
- Migraine With Aura Linked to Incident Ischemic Stroke Risk in Those 45 Years and Older
- ASCO: Modest Accuracy Seen for Existing Breast Cancer Risk Prediction Models
- Handwriting Speed May Be Indicator of Cognitive Impairment
- Quitting Smoking Linked to Lower Risk for Dementia
- Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions